Filip Dubovsky, President, R&D at NOVAVAX INC (NVAX), sold 13,904 shares at $14.46 ($201K) on 2024-06-17, disclosed to the SEC on 2024-06-20.
Open-market sale of $201k NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.46 | 12,500 | $181K | 89.9% |
| 2 | $14.54 | 1,404 | $20K | 10.1% |
| Total | $14.47 avg | 13,904 | $201K | 100% |